Wall Street Analyst Says Hillary Clinton Would be the Best President for Health Care Investors

A 2016 outlook says that Clinton would be good for the industry because she would preserve the Affordable Care Act and be unable to pass meaningful drug reform legislation.

NEW YORK, NY - JUNE 04:  The iconic Wall Street bull is viewed in the early hours of the morning on June 4, 2015 in New York City. Following the deaths of a number of young workers in the finance industry, the 24 hour work culture of many top banks is coming under increased scrutiny. London, New York and San Francisco are just a few of the cities where young employees in the financial sector have recently died in circumstances thought to be related to high stress and a lack of sleep. It is not in common for new employees in banking and finance to go days with little sleep or down time.  (Photo by Spencer Platt/Getty Images)
NEW YORK, NY - JUNE 04: The iconic Wall Street bull is viewed in the early hours of the morning on June 4, 2015 in New York City. Following the deaths of a number of young workers in the finance industry, the 24 hour work culture of many top banks is coming under increased scrutiny. London, New York and San Francisco are just a few of the cities where young employees in the financial sector have recently died in circumstances thought to be related to high stress and a lack of sleep. It is not in common for new employees in banking and finance to go days with little sleep or down time. (Photo by Spencer Platt/Getty Images) Photo: Spencer Platt/Getty Images

Amid a tense battle between Hillary Clinton and Bernie Sanders over competing visions for health care, a leading Wall Street analyst has put out a report saying that Clinton would be the best candidate for health care investors.

In a report titled “Healthcare: Our 2016 Outlook,”Jeffrey Loo of S&P Capital’s IQ Healthcare Equity Research writes that Clinton should be the preferred choice for the industry because she will preserve the Affordable Care Act and be unable to pass meaningful drug reform legislation:

Overall, we believe the best scenario for healthcare investors is a Democrat, presumably Hillary Clinton, winning the Presidency, as we anticipate the Republicans retaining control of Congress. In this scenario, in spite of Clinton’s numerous “threats” to rein in drug prices, allowing the re-importation of drugs, and allowing Medicare to negotiate drug prices, we believe it is highly unlikely Clinton will be able to pass these initiatives through a Republican controlled Congress. Conversely, the Republicans’ efforts to repeal Healthcare Reform, would be thwarted by a Clinton veto as we do not anticipate the Republican obtaining the 2/3 votes to override a veto.

The report makes clear that it views the gridlock created by a Clinton administration paired with a GOP Congress as the rosiest picture for the health care industry.

Clinton has frequently boasted about her record during the 1990s. “I fought really hard,”she said at a Democratic town hall earlier this month. “The insurance companies and the drug companies spent millions against me. I know what it’s like to go up against the status quo and special interests.”

But now, it appears, they’re rooting for her.

Join The Conversation